Ascendis Pharma A/S

ASND·NASDAQ·$239.65Share Price as of 11/2·$15BMarket Cap as of 11/2

Financials

20-FAnnual report (foreign)02/11/26 20-FAnnual report (foreign)02/12/25 20-FAnnual report (foreign)02/07/24 20-FAnnual report (foreign)02/16/23 20-FAnnual report (foreign)03/02/22

Disclosures

6-KForeign issuer report10/26/26 6-KForeign issuer report10/16/26 6-KForeign issuer report10/14/26 6-KForeign issuer report09/29/26 6-KForeign issuer report09/15/26

Prospectuses and Registrations

S-8Registration of securities for employees02/27/26 S-8Registration of securities for employees02/27/25 424B5Prospectus supplement09/20/24 424B5Prospectus supplement09/18/24 F-3ASRProspectus / registration09/18/24

Proxies

No matching filings.

Ownership

Form 4Insider transaction09/28/26 Form 4Insider transaction09/09/26 144Proposed sale of securities09/08/26 Form 4Insider transaction09/03/26 144Proposed sale of securities09/02/26

Other

SDConflict Minerals disclosure05/22/26 8-A12B/A8-A12B/A04/20/26 SDConflict Minerals disclosure05/14/25 SDConflict Minerals disclosure05/29/24 SDConflict Minerals disclosure05/30/23